Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Baxter International (GB:0QK8)
LSE:0QK8
Baxter International (0QK8) Share Price & Analysis
0 Followers
0QK8 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$30.56 - $49.02
Previous Close$37.25
Volume3.52K
Average Volume (3M)4.30K
Market Cap
$18.80B
Enterprise Value$29.91B
Total Cash (Recent Filing)$3.19B
Total Debt (Recent Filing)$14.24B
Price to Earnings (P/E)-80.9
Beta0.58
Next Earnings
Jul 25, 2024EPS EstimateN/A
Last Dividend Ex-Date
Feb 29, 2024Dividend Yield3.14%
Share Statistics
EPS (TTM)-0.46
Shares Outstanding509,580,190
10 Day Avg. Volume0
30 Day Avg. Volume4,305
Standard Deviation0.13
R-Squared0.03
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-4.47
Price to Sales (P/S)5.94
Price to Cash Flow (P/CF)8.80
P/FCF Ratio11.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.02
Enterprise Value/Gross Profit6.01
Enterprise Value/Ebitda34.22
Forecast
1Y Price Target
$44.33Price Target Upside19.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Baxter International News
Bulls Say, Bears Say
Bulls Say
Financial GuidanceThe company has raised its revenue and EPS guidance, signaling confidence in its financial growth trajectory.
Product ApprovalFDA cleared BAX’s Novum IQ large volume pump, a key innovation that may lead to significant unanticipated revenue streams.
Strategic DivestitureAnalyst recommends the sale of KidneyCo, which could provide BAX shareholders with immediate value and potentially yield about $2 billion in cash.
Bears Say
Business IntegrationHill-Rom Healthcare Systems & Technologies integration struggles continued with the business declining 9% in the quarter.
Business Spin-offThe Kidney Care business, set to be spun-off, was a significant outperformance driver, suggesting a possibly more-dilutive RemainCo impact once separated.
Product ApprovalAlaris was approved approximately 7 months ahead of Novum IQ, possibly reducing the anticipated upside for BAX.
---
Options Prices
Currently, No data available
---
Ownership Overview
5.51% Insiders
39.25% Mutual Funds
30.14% Other Institutional Investors
25.10% Public Companies and
Individual Investors
0QK8 FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest share price was $30.56 and its highest was $49.02 in the past 12 months.
What is Baxter International’s market cap?
Currently, no data Available
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Jul 25, 2024 which is in 80 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on May 02, 2024. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.607 by $0.043.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 3.14%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Baxter International have?
Baxter International has 509,580,200 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of $0.65 in its last earnings report, beating expectations of $0.607. Following the earnings report the stock price went down -9.938%.
Which hedge fund is a major shareholder of Baxter International?
Among the largest hedge funds holding Baxter International’s share is Dodge & Cox. It holds Baxter International’s shares valued at 1B.
---
Baxter International Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$44.33 (19.01% Upside)
$44.33 (19.01% Upside)
Blogger Sentiment
Bullish
GB:0QK8 Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.32%
12-Months-Change
Fundamentals
Return on Equity
-0.54%
Trailing 12-Months
Asset Growth
-1.78%
Trailing 12-Months
Company Description
Baxter International
Founded in 1931 and based in Illinois, Baxter International, Inc. provides a portfolio of healthcare products. The company focuses on transformative innovation to deliver smarter, more personalized care for patients and providers. It operates through six global businesses: Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery and Acute Therapies.
---
0QK8 Company Deck
---
0QK8 Earnings Call
Q1 2024
0:00 / 0:00
---
0QK8 Stock 12 Months Forecast
Average Price Target
$44.33
▲(19.01% Upside)
Technical Analysis
Best Analysts Covering 0QK8
1 Year
1 Year Success Rate
7/20 ratings generated profit
1 Year Average Return
-4.88%
assigned a buy rating last month
Copying Matt Miksic's trades and holding each position for 1 Year would result in 35.00% of your transactions generating a profit, with an average return of -4.88% per trade.
---